ISMRM 24th Annual Meeting & Exhibition 07-13 May 2016 Singapore

Educational Session: Cardiac MRI: Non-Ischemic Cardiomyopathies

Skill Level: Intermediate to Advanced

Organizers: Daniel B. Ennis, Ph.D. & Martin J. Graves, Ph.D.

Monday 09 May 2016

Cardiovascular MR is uniquely capable of providing insights in cardiac diseases with preserved ejection fraction. Such conditions are a challenge in clinical cardiology. The session will give information on how to differentiate myocardial injury and how to exploit the unique capabilities of CMR today and in the future.

Target Audience
Clinicians who wish to enhance thier understanding of the routine CMR protocols and who wish to gain exposure to emerging applications. Physicists and engineers, who wish to understand the clinical challenges and to develop ideas to address the missing capabilities of current techniques.

Educational Objectives
Upon completion of this course, participants should be able to:

  • Construct clinical protocols for the differentiation of non-coronary artery disease;
  • Differentiate underlying injury in similiar phenotypes; and
  • Identify routine and emerging techniques in this field.

Moderators: Harald Kramer, Jeanette Schulz-Menger
CMR in Inflammatory Systemic Disorders
Andrew Taylor1,2
1Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia, 2BakerIDI Heart and Diabetes Institute, Melbourne, Australia
Cardiac manifestations are frequently observed in many inflammatory systemic disorders. Identification of cardiac involvement is of high clinical importance, as in many instances a large proportion of the morbidity and mortality in systemic inflammatory diseases is due to cardiac complications, which if identified early may be amenable to therapeutic intervention. In order to simplify the protean cardiac manifestations observed in inflammatory systemic disorders, these diseases can be discussed under the general headings of sarcoidosis, connective tissue diseases, and hypereosinophilic syndromes.

CMR for Identification of Secondary Left Ventricular Hypertrophy
Marianna Fontana1
1University College London
CMR in Metabolic Disorders
Harald Kramer1
1University Hospital Munich
Besides particular cardiac disease like congenital heart disease, ischemic heart disease or myocarditis the heart can be involved in numerous systemic disease entities. These include endstage kidney disease, liver cirrhosis, metabolic syndrome, amyloidosis, autoimmune disorders, hereditary metabolic defects and malignant disease.  Cardiac involvement can include coronary artery disease, valvular disease, endocardial, myocardial or pericardial disorders. Detailed knowledge of the potential cardiac alterations in systemic disease is key in their accurate diagnosis and treatment. 

CMR in Genetic Disorders
Bernd J. Wintersperger1
1Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
Continuous discoveries in genome abnormities result in an ever increasing number of cardiovascular diseases being considered of genetic cause. High importance is furthermore emphasis of either heritable disease or individual mutation caused abnormality. While beyond assessment of genomics, the versatile toolbox of cardiac MRI enables detailed insight into subtle phenotypes that may be linked to changes in genotype (genotype +) and as such provides insight into a possible clinical course of a disease. Furthermore, cardiac MRI provides ongoing excellence in the important aspect of initial diagnosis, therapy monitoring and identification of possible complications in a large variety of genetic CV diseases.

Adjournment & Meet the Teachers

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.